A retrospective, multicenter, observational study of efficacy and safety of darunavir/cobicistat (DRV/c) monotherapy in HIV-infected patients already on suppressive darunavir/ritonavir (DRV/r) monotherapy
Latest Information Update: 13 Aug 2020
At a glance
- Drugs Cobicistat/darunavir (Primary)
- Indications HIV-1 infections
- Focus Adverse reactions; Therapeutic Use
- 13 Aug 2020 New trial record